88 related articles for article (PubMed ID: 18351210)
1. Genetic lesions and the malignant phenotype of haematological cancers.
Vandenberghe P
Verh K Acad Geneeskd Belg; 2007; 69(5-6):291-313. PubMed ID: 18351210
[TBL] [Abstract][Full Text] [Related]
2. Genetic models of human cancer as a multistep process. Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia.
Karakosta A; Golias Ch; Charalabopoulos A; Peschos D; Batistatou A; Charalabopoulos K
J Exp Clin Cancer Res; 2005 Dec; 24(4):505-14. PubMed ID: 16471312
[TBL] [Abstract][Full Text] [Related]
3. [Cancer and oncogenesis].
Bloemena E
Ned Tijdschr Tandheelkd; 2008 Apr; 115(4):180-5. PubMed ID: 18512515
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenesis in haematological malignancies.
Li WW; Hutnik M; Gehr G
Br J Haematol; 2008 Dec; 143(5):622-31. PubMed ID: 19036013
[TBL] [Abstract][Full Text] [Related]
5. The discovery of cellular oncogenes.
Morange M
Hist Philos Life Sci; 1993; 15(1):45-58. PubMed ID: 8310120
[TBL] [Abstract][Full Text] [Related]
6. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
7. Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies.
Hills M; Lansdorp PM
Ann N Y Acad Sci; 2009 Sep; 1176():178-90. PubMed ID: 19796246
[TBL] [Abstract][Full Text] [Related]
8. Advances in individual prediction of methotrexate toxicity: a review.
Schmiegelow K
Br J Haematol; 2009 Sep; 146(5):489-503. PubMed ID: 19538530
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
Tubiana M
Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
[TBL] [Abstract][Full Text] [Related]
10. Is there an association with constitutional structural chromosomal abnormalities and hematologic neoplastic process? A short review.
Panani AD
Ann Hematol; 2009 Apr; 88(4):293-9. PubMed ID: 19129995
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic connections between autoimmune disorders and haematological malignancies.
Javierre BM; Esteller M; Ballestar E
Trends Immunol; 2008 Dec; 29(12):616-23. PubMed ID: 18951845
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders.
Valent P
Blood Rev; 2009 Jul; 23(4):157-65. PubMed ID: 19246139
[TBL] [Abstract][Full Text] [Related]
13. Cell darwinism, apoptosis, free radicals and haematological malignancies.
Cucuianu A
Med Hypotheses; 2001 Jan; 56(1):52-7. PubMed ID: 11133255
[TBL] [Abstract][Full Text] [Related]
14. Natural killer and gammadelta T cells in haematological malignancies: enhancing the immune effectors.
Rey J; Veuillen C; Vey N; Bouabdallah R; Olive D
Trends Mol Med; 2009 Jun; 15(6):275-84. PubMed ID: 19487160
[TBL] [Abstract][Full Text] [Related]
15. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies.
Taniguchi H; Fernández AF; Setién F; Ropero S; Ballestar E; Villanueva A; Yamamoto H; Imai K; Shinomura Y; Esteller M
Cancer Res; 2009 Nov; 69(21):8447-54. PubMed ID: 19861541
[TBL] [Abstract][Full Text] [Related]
17. Cancer immunotherapy.
Baxevanis CN; Perez SA; Papamichail M
Crit Rev Clin Lab Sci; 2009; 46(4):167-89. PubMed ID: 19650714
[TBL] [Abstract][Full Text] [Related]
18. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.
Ebbesen P; Pettersen EO; Gorr TA; Jobst G; Williams K; Kieninger J; Wenger RH; Pastorekova S; Dubois L; Lambin P; Wouters BG; Van Den Beucken T; Supuran CT; Poellinger L; Ratcliffe P; Kanopka A; Görlach A; Gasmann M; Harris AL; Maxwell P; Scozzafava A
J Enzyme Inhib Med Chem; 2009 Apr; 24 Suppl 1():1-39. PubMed ID: 19330638
[TBL] [Abstract][Full Text] [Related]
19. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
Peggs KS; Quezada SA; Allison JP
Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
[TBL] [Abstract][Full Text] [Related]
20. Perspectives of gene expression profiling for diagnosis and therapy in haematological malignancies.
Bacher U; Kohlmann A; Haferlach T
Brief Funct Genomic Proteomic; 2009 May; 8(3):184-93. PubMed ID: 19474126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]